BR112017006533A2 - usos de trealose em suspensões celulares - Google Patents
usos de trealose em suspensões celularesInfo
- Publication number
- BR112017006533A2 BR112017006533A2 BR112017006533A BR112017006533A BR112017006533A2 BR 112017006533 A2 BR112017006533 A2 BR 112017006533A2 BR 112017006533 A BR112017006533 A BR 112017006533A BR 112017006533 A BR112017006533 A BR 112017006533A BR 112017006533 A2 BR112017006533 A2 BR 112017006533A2
- Authority
- BR
- Brazil
- Prior art keywords
- trehalose
- containing medium
- cell suspensions
- cell
- cells
- Prior art date
Links
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 title abstract 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 title abstract 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 title abstract 6
- 239000006285 cell suspension Substances 0.000 title abstract 3
- 230000001413 cellular effect Effects 0.000 abstract 1
- 238000005138 cryopreservation Methods 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000010257 thawing Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462056842P | 2014-09-29 | 2014-09-29 | |
| PCT/US2015/052950 WO2016069173A2 (en) | 2014-09-29 | 2015-09-29 | Uses of trehalose in cell suspensions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017006533A2 true BR112017006533A2 (pt) | 2017-12-19 |
Family
ID=55583355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017006533A BR112017006533A2 (pt) | 2014-09-29 | 2015-09-29 | usos de trealose em suspensões celulares |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160089401A1 (enExample) |
| EP (1) | EP3201319A4 (enExample) |
| JP (1) | JP2017531446A (enExample) |
| CN (1) | CN107106488A (enExample) |
| AU (1) | AU2015339886B2 (enExample) |
| BR (1) | BR112017006533A2 (enExample) |
| CA (1) | CA2962239C (enExample) |
| WO (1) | WO2016069173A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12497594B2 (en) | 2020-05-08 | 2025-12-16 | Gallant Pet, Inc. | Uterine-derived regenerative cell compositions and uses thereof |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3525806B1 (en) * | 2016-10-12 | 2023-02-15 | Agency For Science, Technology And Research | Method for lyophilising an exosome |
| GB201716729D0 (en) * | 2017-10-12 | 2017-11-29 | Asymptote Ltd | Cryopreservation method and apparatus |
| US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
| CN111856022A (zh) * | 2020-07-01 | 2020-10-30 | 山东凯歌智能机器有限公司 | 一种检测胰腺癌患者外周血循环肿瘤细胞E-Cadherin表达的试剂盒及检测方法 |
| CN111638341A (zh) * | 2020-07-01 | 2020-09-08 | 山东凯歌智能机器有限公司 | 一种检测小细胞肺癌患者外周血循环肿瘤细胞pd-l1基因突变的试剂盒及检测方法 |
| EP4181675A4 (en) | 2020-07-18 | 2024-04-24 | Ossium Health, Inc. | PERMEATION OF WHOLE VERTEBRATE BODIES WITH A CRYOPRETECTIVE AGENT USING VACUUM-ASSISTED DIFFUSION |
| CA3195653A1 (en) | 2020-10-14 | 2022-04-21 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
| WO2022133282A1 (en) | 2020-12-18 | 2022-06-23 | Ossium Health, Inc. | Methods of cell therapies |
| US20240060049A1 (en) | 2020-12-19 | 2024-02-22 | Habil F KHORAKIWALA | Lyophilized mesenchymal stem cells |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2194911T3 (es) * | 1994-06-02 | 2003-12-01 | Elan Drug Delivery Ltd | Metodo para evitar la agregacion de proteinas/peptidos cuando tiene lugar su rehidratacion o descongelacion. |
| DE59804785D1 (de) * | 1997-11-22 | 2002-08-22 | Roche Diagnostics Gmbh | Verbessertes Verfahren zur Stabilisierung von Proteinen |
| US20060134596A1 (en) * | 2003-05-08 | 2006-06-22 | Anita Sjogren | Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
| EP1841856A1 (en) * | 2005-01-28 | 2007-10-10 | Canadian Blood Services | A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
| CA2635978A1 (en) * | 2006-01-04 | 2007-07-12 | Do-Coop Technologies Ltd. | Solid-fluid composition |
| KR20240052847A (ko) * | 2008-08-20 | 2024-04-23 | 셀룰래리티 인코포레이티드 | 개선된 세포 조성물 및 그의 제조 방법 |
| JP5940975B2 (ja) * | 2009-07-20 | 2016-06-29 | ザ ジェネラル ホスピタル コーポレーション ディー／ビー／エイ マサチューセッツ ジェネラル ホスピタル | 凍結保存細胞の生存率を向上させるための方法および組成物 |
| CN103180435A (zh) * | 2010-08-31 | 2013-06-26 | 库克通用生物技术有限责任公司 | 用于治疗动物疾病的全身的同种异体干细胞疗法 |
| JP5341059B2 (ja) * | 2010-11-09 | 2013-11-13 | 株式会社大塚製薬工場 | 幹細胞懸濁液 |
| MX370199B (es) * | 2012-02-16 | 2019-12-05 | Santarus Inc | Composiciones farmaceuticas de anticuerpo anti-antigeno muy tardio (cd49a). |
| JP5432322B2 (ja) * | 2012-05-08 | 2014-03-05 | 株式会社大塚製薬工場 | トレハロース含有肺塞栓形成予防用哺乳動物細胞懸濁液 |
| JP5196618B1 (ja) * | 2012-09-28 | 2013-05-15 | 株式会社大塚製薬工場 | トレハロース含有細胞洗浄溶液を用いた接着細胞の洗浄方法 |
| CN104161037B (zh) * | 2014-08-13 | 2016-01-13 | 江苏丘陵地区镇江农业科学研究所 | 一种山羊精液玻璃化冷冻和解冻配方与方法 |
| CN105052894B (zh) * | 2015-08-26 | 2018-03-06 | 中国农业科学院特产研究所 | 一种gv期卵母细胞冷冻保存液及冷冻保存方法 |
-
2015
- 2015-09-29 CN CN201580062294.3A patent/CN107106488A/zh active Pending
- 2015-09-29 WO PCT/US2015/052950 patent/WO2016069173A2/en not_active Ceased
- 2015-09-29 JP JP2017536231A patent/JP2017531446A/ja active Pending
- 2015-09-29 CA CA2962239A patent/CA2962239C/en active Active
- 2015-09-29 BR BR112017006533A patent/BR112017006533A2/pt not_active Application Discontinuation
- 2015-09-29 US US14/869,006 patent/US20160089401A1/en not_active Abandoned
- 2015-09-29 AU AU2015339886A patent/AU2015339886B2/en active Active
- 2015-09-29 EP EP15854446.0A patent/EP3201319A4/en not_active Withdrawn
-
2021
- 2021-05-07 US US17/302,633 patent/US20210252155A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12497594B2 (en) | 2020-05-08 | 2025-12-16 | Gallant Pet, Inc. | Uterine-derived regenerative cell compositions and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017531446A (ja) | 2017-10-26 |
| US20160089401A1 (en) | 2016-03-31 |
| WO2016069173A3 (en) | 2016-07-28 |
| CA2962239A1 (en) | 2016-05-06 |
| EP3201319A2 (en) | 2017-08-09 |
| US20210252155A1 (en) | 2021-08-19 |
| CN107106488A (zh) | 2017-08-29 |
| AU2015339886A1 (en) | 2017-04-13 |
| AU2015339886B2 (en) | 2019-05-09 |
| EP3201319A4 (en) | 2018-05-16 |
| WO2016069173A2 (en) | 2016-05-06 |
| CA2962239C (en) | 2024-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017006533A2 (pt) | usos de trealose em suspensões celulares | |
| MX2022003477A (es) | Medio de cultivo celular complementado con taurina y metodos de uso. | |
| BR112017022045A2 (pt) | composição e kits para matrizes de microgel pseudoplástico | |
| MX2025009360A (es) | Medios y metodo para preparar vectores virales y usos de los mismos | |
| CL2017001139A1 (es) | Composiciones de antibiótico | |
| MX389749B (es) | Sistemas y métodos para el uso simultáneo del espectro dentro del espectro usado activamente. | |
| EP4545544A3 (en) | Modified crispr rna and modified single crispr rna and uses thereof | |
| BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
| MX380438B (es) | Nuevo polisacárido y usos del mismo. | |
| CL2015003599A1 (es) | Solucion que contiene theralosa y dextrano para transplantar celulas de mamiferos | |
| BR112016007375A2 (pt) | conjuntos de procedimentos para habilitar comunicações sem fio com o uso de estruturas de subquadro que tenham diferentes durações de subquadro | |
| MX2017013098A (es) | Enzimas y aplicaciones de las mismas. | |
| DK3284816T3 (da) | Dyrkningsmedietilsætningsstof, dyrkningsmediesammensætning og fremgangsmåde til at dyrke celler eller væv ved anvendelse af samme | |
| CL2017002427A1 (es) | Producción de ácido ribonucleico libre de células. | |
| UY34036A (es) | Composición que comprende aflibercept, ácido folínico, 5-fluorouracilo (5-FU) e irinotecano (FOLFIRI). | |
| EA201990032A1 (ru) | Способы и композиции для терапии посредством потенциирования стволовых клеток | |
| BR112014003139A2 (pt) | musgo de turfa umectável resistente à lixiviação, método de preparação, e método de uso | |
| BR112017016897A2 (pt) | cepas fúngicas e métodos de uso | |
| BR112016013322A2 (pt) | Métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit | |
| BR112018010676A2 (pt) | polipeptídeo termoestável, uso e meio de cultura | |
| BR112016007251A2 (pt) | método de processamento de biomassa que contém celulose | |
| MX2018015439A (es) | Conservacion de microorganismos. | |
| MX2017000076A (es) | Macromoleculas estrellas compatibles con tensoactivos. | |
| BR112018070084A2 (pt) | composições de célula viável, e métodos relacionados às mesmas | |
| BR112016021739A2 (pt) | Método para preparar um poloxâmero para uso em um meio de cultura de célula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |